Psychiatry

Recent surveys reveal that 40.9% of 5470 respondents are suffering from adverse mental or behavioral health conditions related to the pandemic.

Low- and moderate-frequency magnetic seizure therapy help patients with treatment-resistant depression go into remission.

A number of new modifiable risk factors for depression were identified including confiding in others, time spent watching television, and daytime napping.

As every practitioner knows, it is difficult to support staff while deliberately seeing fewer patients to save one’s own soul.

According to new findings, low Glx response is associated with increase in clinical improvements in at-need patients.

The risk of depression or clinically relevant depressive symptoms did not significantly differ between a group taking Vitamin D and a group taking a placebo.

MagVenture TMS Therapy can be used as adjunctive therapy to other OCD treatments.

A leading psychiatric expert discusses some of the pitfalls people face due to the ongoing pandemic.

Approximately half of depression patients do not sufficiently benefit after treated with electroconvulsive therapy, leading to high rates of relapses.

The level of distress for adults in the UK rose from 18.9% in 2018-19 to 27.3% in April.

The fast-acting therapy has been long-discussed for its unique benefits to severe patients—as well as notable concerns surrounding its administration.

Impairment in reward-processing subcomponent categories is associated with tasks assessing option valuation, reward bias, and reinforcement learning.

Interim findings from a cross-sectional study shows a correlation between worse cognitive scoring and a greater rate of intravitreal injections.

The findings demonstrate the importance of providers to manage diabetes, diabetic retinopathy, and mental illness comorbidities.

Patients in the DBT group were less likely to drop out early and had higher rates of symptomatic remission than a comparison CPT treatment group.

Both telemedicine and face-to-face therapy resulted in improved daytime function.

The risk of reoffended is lower in males with 5 or more clinical contacts.

The number needed to treat to prevent at least 1 additional hospitalization was 7 individuals treated with aripiprazole once monthly compared with clinician’s choice.

The investigators found the treatment’s value-based price was approximately $140/dose ,while the current price is $240/dose.

Four out of 18 patients in antipsychotic monotherapy, 5 out of 16 individuals receiving psychological intervention, and 5 out of 17 receiving combined therapy achieved a good clinical response at 6 months.

Patients with bipolar depression have struggled during the COVID-19 pandemic.

Unlike other antidepressants, SEP-4199 looks at reducing some side effects common when treating bipolar depression.

The best results came from second-stage therapies, which produced significant increases in remission and response rates.

Shorter nighttime sleep duration and later bedtime at 3.5 years old age were significantly associated with borderline personality disorder symptoms.

The presence of anxiety symptoms moderated most alterations in emotional processing observed following sleep restriction.